Appointment strengthens leadership team to drive strategy focused on harnessing 3D multi-omics to identify high-confidence, high-value therapeutic targets, to accelerate drug discovery CAMBRIDGE, ...
EDINBURGH, Scotland, May 6, 2025 /PRNewswire/ -- Wobble Genomics, a biotechnology company working to improve outcomes in cancer through better diagnosis and therapy selection, via a novel ...
Even to Dietrich Stephan, a genetic researcher shopping his idea for a potentially revolutionary $400 million molecular laboratory, it all sounds like science fiction. He says he's trying to "change ...
Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results